Literature DB >> 7512369

Identification of a novel protein with GDP dissociation inhibitor activity for the ras-like proteins CDC42Hs and rac I.

C N Adra1, J Ko, D Leonard, L J Wirth, R A Cerione, B Lim.   

Abstract

We have recently cloned the human cDNA for a gene, denoted D4, that encodes a protein 67% identical to the bovine rhoGDI protein, a GDP dissociation inhibitor (GDI) for the ras-related rho-subtype proteins. We now present data on the cloning and structural analysis of the murine D4 cDNA and confirm its preferential expression in hematopoietic tissues. The predicted murine and human D4 proteins are almost 90% identical, indicating that D4 and rhoGDI are different genes and that they are probably members of a related family of genes. Functional studies with the human D4 protein demonstrate that D4 has GDI activity against the CDC42Hs and rac I proteins, but binds to these proteins with a significantly weaker affinity than does the rho-subtype GDI. These data suggest that D4, which will in subsequent communications be denoted as GDI.D4, might be a GDI for other known or as yet unidentified ras-like GTP-binding proteins. Alternatively, D4 could have other biochemical functions. During murine embryogenesis, D4 transcripts are detected in yolk-sac cells, where the earliest hematopoietic precursors are found. When these precursors undergo proliferation and differentiation in vitro, a dramatic increase in D4 expression is seen. D4 probably has a significant function during the growth and development of hematopoietic precursors.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7512369     DOI: 10.1002/gcc.2870080408

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  12 in total

1.  Identification of a novel Rac1-interacting protein involved in membrane ruffling.

Authors:  L Van Aelst; T Joneson; D Bar-Sagi
Journal:  EMBO J       Date:  1996-08-01       Impact factor: 11.598

2.  RhoGDIgamma: a GDP-dissociation inhibitor for Rho proteins with preferential expression in brain and pancreas.

Authors:  C N Adra; D Manor; J L Ko; S Zhu; T Horiuchi; L Van Aelst; R A Cerione; B Lim
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-29       Impact factor: 11.205

Review 3.  Cdc42: An essential Rho-type GTPase controlling eukaryotic cell polarity.

Authors:  D I Johnson
Journal:  Microbiol Mol Biol Rev       Date:  1999-03       Impact factor: 11.056

4.  A single residue can modify target-binding affinity and activity of the functional domain of the Rho-subfamily GDP dissociation inhibitors.

Authors:  J V Platko; D A Leonard; C N Adra; R J Shaw; R A Cerione; B Lim
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

5.  Stimulation of phospholipase C-beta2 by the Rho GTPases Cdc42Hs and Rac1.

Authors:  D Illenberger; F Schwald; D Pimmer; W Binder; G Maier; A Dietrich; P Gierschik
Journal:  EMBO J       Date:  1998-11-02       Impact factor: 11.598

6.  Immunological and Functional Characterization of RhoGDI3 and Its Molecular Targets RhoG and RhoB in Human Pancreatic Cancerous and Normal Cells.

Authors:  Mercedes Piedad de León-Bautista; Maria Del Carmen Cardenas-Aguayo; Diana Casique-Aguirre; Manuel Almaraz-Salinas; Sara Parraguirre-Martinez; Angelica Olivo-Diaz; María Del Rocío Thompson-Bonilla; Miguel Vargas
Journal:  PLoS One       Date:  2016-11-10       Impact factor: 3.240

Review 7.  MicroRNA Regulation of the Small Rho GTPase Regulators-Complexities and Opportunities in Targeting Cancer Metastasis.

Authors:  Brock A Humphries; Zhishan Wang; Chengfeng Yang
Journal:  Cancers (Basel)       Date:  2020-04-28       Impact factor: 6.639

8.  Protein expression profile changes of lung tissue in patients with pulmonary hypertension.

Authors:  Min Wu; Yijin Wu; Jinsong Huang; Yueheng Wu; Hongmei Wu; Benyuan Jiang; Jian Zhuang
Journal:  PeerJ       Date:  2020-01-31       Impact factor: 2.984

9.  Proteomic analysis of differently expressed proteins in a mouse model for allergic asthma.

Authors:  HoeSu Jeong; TaiYoun Rhim; Mi-Hyun Ahn; Pyoung-Oh Yoon; Sung-Ho Kim; Il Yup Chung; SooTaek Uh; Sung-Il Kim; Choon-Sik Park
Journal:  J Korean Med Sci       Date:  2005-08       Impact factor: 2.153

10.  A Complete Survey of RhoGDI Targets Reveals Novel Interactions with Atypical Small GTPases.

Authors:  Ana Masara Binti Ahmad Mokhtar; Samrein B M Ahmed; Nicola J Darling; Matthew Harris; Helen R Mott; Darerca Owen
Journal:  Biochemistry       Date:  2021-04-29       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.